AXMIX
Price
$15.15
Change
-$0.53 (-3.38%)
Updated
Dec 18 closing price
FSMAX
Price
$91.53
Change
-$4.22 (-4.41%)
Updated
Dec 18 closing price
Ad is loading...

AXMIX vs FSMAX

Header iconAXMIX vs FSMAX Comparison
Open Charts AXMIX vs FSMAXBanner chart's image
Acclivity Mid Cap Multi-Style I
Price$15.15
Change-$0.53 (-3.38%)
VolumeN/A
CapitalizationN/A
Fidelity Extended Market Index
Price$91.53
Change-$4.22 (-4.41%)
VolumeN/A
CapitalizationN/A
AXMIX vs FSMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AXMIX vs. FSMAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXMIX is a StrongBuy and FSMAX is a Hold.

FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 44.5B vs. AXMIX (4.84M). FSMAX pays higher dividends than AXMIX: FSMAX (1.10) vs AXMIX (0.54). AXMIX was incepted earlier than FSMAX: AXMIX (5 years) vs FSMAX (13 years). AXMIX is a more actively managed with annual turnover of: 53.00 vs. FSMAX (18.00). FSMAX has a lower initial minimum investment than AXMIX: FSMAX (0) vs AXMIX (20000). FSMAX annual gain was more profitable for investors over the last year : 24.85 vs. AXMIX (18.01).
AXMIXFSMAXAXMIX / FSMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years13 years-
Gain YTD16.87322.66274%
Front LoadN/AN/A-
Min. Initial Investment200000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.84M44.5B0%
Annual Yield % from dividends0.541.1050%
Returns for 1 year18.0124.8572%
Returns for 3 years24.8315.90156%
Returns for 5 yearsN/A54.67-
Returns for 10 yearsN/A88.57-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HSAI13.923.72
+36.47%
Hesai Group American Depositary Share each ADS represents one
STRA99.76-1.86
-1.83%
Strategic Education
KNSL491.06-11.01
-2.19%
Kinsale Capital Group
LOOP1.60-0.14
-8.05%
Loop Industries
MBRX1.86-0.33
-15.07%
Moleculin Biotech